Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01844414 · ClinicalTrials.gov registry record · NA

UCLA-Amity Parolee Health Promotion Study

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
600
Enrollment target

NCT01844414 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 600 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01844414, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
600 participants
Enrollment target

Study Summary

The purpose of this study is to conduct a prospective, three-group study that randomly assigns 700 parolees, in a community residential drug treatment program, to enter one of three groups: 1) a PCPC (Parolee Comprehensive Care + Phone Coaching Program), which includes nurse case management and specialized hepatitis education sessions and the hepatitis A/B (HAV/HBV) vaccination series (to all eligible) and coach-facilitated mentoring (mostly by cell-phone); 2) a Parolee Brief Hepatitis Education + HBV vaccination + Phone Coaching (PBCP) Program, which includes brief hepatitis/HIV education, HAV/HBV vaccination and coach-facilitated mentoring; or 3) a Usual Care (UC) control program, which includes brief general health information, one-on-one coaching and the HAV/HBV vaccine.

Interventions

  • BEHAVIORAL Usual Care Group
  • BEHAVIORAL Parolee Comprehensive Care + Phone Coach
  • BEHAVIORAL Parolee Brief HBV Program + Phone Coach

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2010-02
Est. Completion 2015-05
Phase NA

What the Registry Record Tells You About NCT01844414

The ClinicalTrials.gov registry entry for NCT01844414 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Usual Care Group is the first listed.

NCT01844414 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01844414 about?

NCT01844414 is a clinical study titled "UCLA-Amity Parolee Health Promotion Study". The purpose of this study is to conduct a prospective, three-group study that randomly assigns 700 parolees, in a community residential drug treatment program, to enter one of three groups: 1) a PCPC (Parolee Comprehensive Care + Phone Coaching Program), which includes nurse case management and spec...

What is the current status of trial NCT01844414?

This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2010-02. Estimated completion is 2015-05.

What interventions are being tested in trial NCT01844414?

The interventions under investigation include: Usual Care Group (BEHAVIORAL), Parolee Comprehensive Care + Phone Coach (BEHAVIORAL), Parolee Brief HBV Program + Phone Coach (BEHAVIORAL).

Who is sponsoring clinical trial NCT01844414?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.